Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke

Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke

Aim: to study the role of amyloid-beta 40 (Aβ 40) in the development of cognitive impairment in acute ischemic stroke.Materials and methods. The study included 70 patients aged 33–86 years, 46 men and 24 women. In patients with acute ischemic stroke cognitive status was assessed with Mini-Mental Sta...

Full description

Bibliographic Details
Main Authors: Aleksey A. Kulesh, Viktor E. Drobakha, Elena M. Kuklina, Vladimir V. Shestakov
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2017-10-01
Series:Бюллетень сибирской медицины
Subjects:
инсульт
амилоид
нейродегенерация
когнитивные нарушения
Online Access:https://bulletin.ssmu.ru/jour/article/view/958

Similar Items

Similar Items